Skip to content
10-Q

Quarterly Report

THC THERAPEUTICS, INC.

0001477932-24-004626

← back to feed
Filed
Aug 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Jul 23, 2024 32.75M sh
Operating Cash Flow Q1 2024 · Oct 31, 2023 −$269
Operating Cash Flow Q1 2024 · Oct 31, 2022 −$21.49K
Stockholders Equity Q1 2024 · Oct 31, 2023 −$3.37M
Stockholders Equity Q1 2024 · Jul 31, 2023 −$3.31M
Stockholders Equity Q1 2024 · Oct 31, 2022 −$5.22M
Stockholders Equity Q1 2024 · Jul 31, 2022 −$3.11M
Current Liabilities Q1 2024 · Oct 31, 2023 $3.28M
Current Liabilities Q1 2024 · Jul 31, 2023 $3.22M
Total Liabilities Q1 2024 · Oct 31, 2023 $3.28M
Total Liabilities Q1 2024 · Jul 31, 2023 $3.22M
Current Assets Q1 2024 · Oct 31, 2023 $10
Current Assets Q1 2024 · Jul 31, 2023 $980
Total Assets Q1 2024 · Oct 31, 2023 $11.67K
Total Assets Q1 2024 · Jul 31, 2023 $12.99K
Net Income Q1 2024 · Oct 31, 2023 −$62.49K
Net Income Q1 2024 · Oct 31, 2022 −$2.13M
Operating Income Q1 2024 · Oct 31, 2023 −$55.22K
Operating Income Q1 2024 · Oct 31, 2022 −$107.56K
Gross Profit Q1 2024 · Oct 31, 2023 $0
Gross Profit Q1 2024 · Oct 31, 2022 $0
Cost Of Revenue Q1 2024 · Oct 31, 2023 $0
Cost Of Revenue Q1 2024 · Oct 31, 2022 $0
Revenue Q1 2024 · Oct 31, 2023 $0
Revenue Q1 2024 · Oct 31, 2022 $0